'PAC(Pharma Associations Conference) 2014'_KDDF Session
Session M-2: Essence of KDDF(Korea Drug Development Fund) Projects
Chair: Young-Guen Kwon, Yonsei University
- Kyeong- Cheon Jung, Dinona Inc.
“JL1 epitope of CD43, a novel therapeutic target in acute leukemia”
-
- Sanghee, Yoo, PhD, Hanall Biopharma./
“HL161: a Novel Anti-FcRn Antibody as a New Therapeutic Option for Autoimmune Diseases”
-
- Yoon-Won Kim, ImmuneMed Inc.
“Development of newly defined antiviral drug that selectively acts on the viral infected cells”